drugset / Trial / NCT06876701
The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults
NaSingle-groupOpen-labelTreatment
Summary
Evaluation the efficacy and safety of the combination of injectable bevacizumab, low-intensity chemotherapy, and venula in the treatment of newly diagnosed CD19+mixed phenotype acute leukemia in adults
Timeline
- Start
- 2025-04-01
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | — | Other |